Post-Marketing Surveillance of Herceptin Subcutaneous in Breast Cancer
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Adverse reactions
- Sponsors Roche
- 01 Jul 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
- 11 May 2015 Planned initiation date changed from 1 Feb 2015 to 1 May 2015, according to ClinicalTrials.gov record.
- 05 May 2015 Planned initiation date changed from 1 May 2015 to 1 Feb 2015, according to ClinicalTrials.gov record.